Nuvectis Pharma, Inc. (NASDAQ:NVCT) is held by 47 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 845,502 | 146,794 | 21.01% | $6,383,541.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 782,805 | 97,468 | 14.22% | $5,910,179.00 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 31 Dec, 2025 | 586,320 | 180,699 | 44.55% | $4,426,716.00 |
| BALDWIN WEALTH PARTNERS LLC/MA | 31 Dec, 2025 | 389,625 | 39,164 | 11.17% | $2,941,669.00 |
| Occam Crest Management LP | 31 Dec, 2025 | 380,000 | 90,000 | 31.03% | $2,869,000.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 364,024 | 38,291 | 11.76% | $2,748,937.00 |
| State Street Corp | 31 Dec, 2025 | 154,666 | 17,950 | 13.13% | $1,167,728.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Dec, 2025 | 134,154 | 43,275 | 47.62% | $1,012,863.00 |
| Northern Trust Corp | 31 Dec, 2025 | 116,405 | 9,764 | 9.16% | $878,857.00 |
| OPPENHEIMER & CO INC | 31 Dec, 2025 | 73,566 | 4,500 | 6.52% | $555,423.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 53,006 | 7,843 | 17.37% | $400,196.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 44,022 | 6,040 | 15.90% | $332,366.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 31,635 | 3,564 | 12.70% | $238,847.00 |
| Morgan Stanley | 31 Dec, 2025 | 28,011 | 9,494 | 51.27% | $211,484.00 |
| Barclays Plc | 31 Dec, 2025 | 24,185 | -13,809 | -36.35% | $182,596.00 |
| Austin Wealth Management, LLC | 31 Dec, 2025 | 20,125 | 0 | 0.00% | $178,106.00 |
| Wells Fargo & Company/Mn | 31 Dec, 2025 | 16,929 | 9,022 | 114.10% | $127,814.00 |
| Nuveen, LLC | 31 Dec, 2025 | 16,749 | 0 | 0.00% | $126,455.00 |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 31 Dec, 2025 | 15,170 | 0 | 0.00% | $114,534.00 |
| CIBC Private Wealth Group LLC | 31 Dec, 2025 | 14,574 | 14,574 | 0.00% | $110,034.00 |